Literature DB >> 18708004

Neurologic damage and neurocognitive dysfunction in urea cycle disorders.

Gregory M Enns1.   

Abstract

Although the survival of patients who have urea cycle disorders has improved with the use of modalities such as alternative pathway therapy and hemodialysis, neurologic outcome is suboptimal. Patients often manifest with a variety of neurologic abnormalities, including cerebral edema, seizures, cognitive impairment, and psychiatric illness. Current hypotheses of the pathogenesis underlying brain dysfunction in these patients have focused on several lines of investigation, including the role of glutamine in causing cerebral edema, mitochondrial dysfunction leading to energy failure and the production of free radicals, and altered neurotransmitter metabolism. Advances in understanding the pathogenetic mechanisms underlying brain impairment in urea cycle disorders may lead to the development of therapies designed to interfere with the molecular cascade that ultimately leads to cerebral edema and other brain pathological findings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708004     DOI: 10.1016/j.spen.2008.05.007

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  27 in total

1.  Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders--review and meta-analysis of observational studies published over more than 35 years.

Authors:  Peter Burgard; Stefan Kölker; Gisela Haege; Martin Lindner; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2015-12-03       Impact factor: 4.982

Review 2.  Urea cycle disorder misdiagnosed as multiple sclerosis: a case report and review of the literature.

Authors:  Hussein Algahtani; Seham Alameer; Yousef Marzouk; Bader Shirah
Journal:  Neuroradiol J       Date:  2017-06-21

3.  Clinical Reasoning: An encephalopathic 3-day-old infant.

Authors:  A A Gelfand; A Sznewajs; H C Glass; A C Jelin; E H Sherr
Journal:  Neurology       Date:  2011-07-05       Impact factor: 9.910

4.  Favorable long-term outcome following severe neonatal hyperammonemic coma in a patient with argininosuccinate synthetase deficiency.

Authors:  Isabelle De Bie; Emmanuelle Lemyre; Marie Lambert
Journal:  JIMD Rep       Date:  2011-06-22

5.  Biochemical markers and neuropsychological functioning in distal urea cycle disorders.

Authors:  Susan E Waisbren; David Cuthbertson; Peter Burgard; Amy Holbert; Robert McCarter; Stephen Cederbaum
Journal:  J Inherit Metab Dis       Date:  2018-02-08       Impact factor: 4.982

Review 6.  Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review.

Authors:  Francesco Giuseppe Foschi; Maria Cristina Morelli; Sara Savini; Anna Chiara Dall'Aglio; Arianna Lanzi; Matteo Cescon; Giorgio Ercolani; Alessandro Cucchetti; Antonio Daniele Pinna; Giuseppe Francesco Stefanini
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

7.  Education of a child neurologist: developmental neuroscience relevant to child neurology.

Authors:  Michael V Johnston
Journal:  Semin Pediatr Neurol       Date:  2011-06       Impact factor: 1.636

8.  Post-treatment with voltage-gated Na(+) channel blocker attenuates kainic acid-induced apoptosis in rat primary hippocampal neurons.

Authors:  Arabinda Das; Misty McDowell; Casey M O'Dell; Megan E Busch; Joshua A Smith; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2010-12-03       Impact factor: 3.996

Review 9.  Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

Review 10.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.